Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

Top Cited Papers
Open Access
Abstract
Key Points Most cases of ibrutinib-resistant CLL were due to mutations in BTK and/or PLCG2 and often composed of multiple independent subclones. High sensitivity testing identified resistance mutations up to 15 months before manifestation of clinical progression.

This publication has 46 references indexed in Scilit: